SCHEMBL23234756

SCHEMBL23234756

COn1c(=O)[nH]c(=O)c2cccnc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
LDHA P00338 1/20 0.44
KDM4D Q6B0I6 2/20 0.44
PARP1 P09874 3/20 0.42
AURKA O14965 1/20 0.42
MAPT P10636 2/20 0.41
DAO P14920 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
FEN1 P39748 2/20 0.39
PDE2A O00408 1/20 0.39
PDE6D O43924 1/20 0.39
PDE8A O60658 1/20 0.39
PDE5A O76074 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2023608 0.84 HPGD (0.45) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL6027612 0.82 FEN1 (0.55) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL12640845 0.79 HPGD (0.44) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL2027361 0.78 HCAR2 (0.48) HPGDCYP1A2CYP2C19CYP2C9MAPT
SCHEMBL2027130 0.77 LDHA (0.45) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL5251146 0.72 LDHA (0.59) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL9497347 0.71 HPGD (0.47) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL6723798 0.69 NPC1 (0.43) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL14642161 0.69 KDM4D (0.45) HPGDCYP1A2CYP2C19CYP2C9LDHA
SCHEMBL11366776 0.69 HPGD (0.62) HPGDCYP1A2CYP2C19CYP2C9LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3807276-A2 KRAS G12C INHIBITORS ENCOMPASSING A PIPERAZINE RING AND USE THEREOF IN THE TREATMENT OF CANCER Amgen Inc. (US) 2021-04-21 EP disclosed